177 related articles for article (PubMed ID: 18538007)
1. Antagonist affinity measurements at the Gi-coupled human histamine H3 receptor expressed in CHO cells.
Baker JG
BMC Pharmacol; 2008 Jun; 8():9. PubMed ID: 18538007
[TBL] [Abstract][Full Text] [Related]
2. No evidence for functional selectivity of proxyfan at the human histamine H3 receptor coupled to defined Gi/Go protein heterotrimers.
Schnell D; Burleigh K; Trick J; Seifert R
J Pharmacol Exp Ther; 2010 Mar; 332(3):996-1005. PubMed ID: 19959746
[TBL] [Abstract][Full Text] [Related]
3. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
Krueger KM; Witte DG; Ireland-Denny L; Miller TR; Baranowski JL; Buckner S; Milicic I; Esbenshade TA; Hancock AA
J Pharmacol Exp Ther; 2005 Jul; 314(1):271-81. PubMed ID: 15821027
[TBL] [Abstract][Full Text] [Related]
4. A study of antagonist affinities for the human histamine H2 receptor.
Baker JG
Br J Pharmacol; 2008 Mar; 153(5):1011-21. PubMed ID: 18157166
[TBL] [Abstract][Full Text] [Related]
5. Protean agonism at histamine H3 receptors in vitro and in vivo.
Gbahou F; Rouleau A; Morisset S; Parmentier R; Crochet S; Lin JS; Ligneau X; Tardivel-Lacombe J; Stark H; Schunack W; Ganellin CR; Schwartz JC; Arrang JM
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):11086-91. PubMed ID: 12960366
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the antagonist affinities for the Gi- and Gs-coupled states of the human adenosine A1-receptor.
Baker JG; Hill SJ
J Pharmacol Exp Ther; 2007 Jan; 320(1):218-28. PubMed ID: 17018691
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetic properties of the histamine H3 receptor protean agonist proxyfan.
Henry MB; Zheng S; Duan C; Patel B; Vassileva G; Sondey C; Lachowicz J; Hwa JJ
Endocrinology; 2011 Mar; 152(3):828-35. PubMed ID: 21239440
[TBL] [Abstract][Full Text] [Related]
8. Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors.
Rouleau A; Ligneau X; Tardivel-Lacombe J; Morisset S; Gbahou F; Schwartz JC; Arrang JM
Br J Pharmacol; 2002 Jan; 135(2):383-92. PubMed ID: 11815373
[TBL] [Abstract][Full Text] [Related]
9. The H3 receptor protean agonist proxyfan enhances the expression of fear memory in the rat.
Baldi E; Bucherelli C; Schunack W; Cenni G; Blandina P; Passani MB
Neuropharmacology; 2005 Feb; 48(2):246-51. PubMed ID: 15695163
[TBL] [Abstract][Full Text] [Related]
10. Differential homologous desensitization of the human histamine H
García-Gálvez AM; Escamilla-Sánchez J; Flores-Maldonado C; Contreras RG; Arias JM; Arias-Montaño JA
Neurochem Int; 2018 Jan; 112():114-123. PubMed ID: 29162484
[TBL] [Abstract][Full Text] [Related]
11. Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.
Witte DG; Yao BB; Miller TR; Carr TL; Cassar S; Sharma R; Faghih R; Surber BW; Esbenshade TA; Hancock AA; Krueger KM
Br J Pharmacol; 2006 Jul; 148(5):657-70. PubMed ID: 16715122
[TBL] [Abstract][Full Text] [Related]
12. The signaling and selectivity of α-adrenoceptor agonists for the human α2A, α2B and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors.
Proudman RGW; Akinaga J; Baker JG
Pharmacol Res Perspect; 2022 Oct; 10(5):e01003. PubMed ID: 36101495
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists.
Wieland K; Bongers G; Yamamoto Y; Hashimoto T; Yamatodani A; Menge WM; Timmerman H; Lovenberg TW; Leurs R
J Pharmacol Exp Ther; 2001 Dec; 299(3):908-14. PubMed ID: 11714875
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of recombinantly expressed rat and human histamine H3 receptors.
Wulff BS; Hastrup S; Rimvall K
Eur J Pharmacol; 2002 Oct; 453(1):33-41. PubMed ID: 12393057
[TBL] [Abstract][Full Text] [Related]
15. H3 receptor-mediated inhibition of intestinal acetylcholine release: pharmacological characterization of signal transduction pathways.
Blandizzi C; Colucci R; Tognetti M; De Paolis B; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):193-202. PubMed ID: 11219402
[TBL] [Abstract][Full Text] [Related]
16. Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists.
Riddy DM; Cook AE; Diepenhorst NA; Bosnyak S; Brady R; Mannoury la Cour C; Mocaer E; Summers RJ; Charman WN; Sexton PM; Christopoulos A; Langmead CJ
Mol Pharmacol; 2017 Feb; 91(2):87-99. PubMed ID: 27864425
[TBL] [Abstract][Full Text] [Related]
17. Proxyfan acts as a neutral antagonist of histamine H3 receptors in the feeding-related hypothalamic ventromedial nucleus.
Clapp RH; Luckman SM
Br J Pharmacol; 2012 Nov; 167(5):1099-110. PubMed ID: 22646302
[TBL] [Abstract][Full Text] [Related]
18. A Novel Potent and Selective Histamine H
Hino N; Marumo T; Kotani M; Shimazaki T; Kaku-Fukumoto A; Hikichi H; Karasawa JI; Tomishima Y; Komiyama H; Tatsuda E; Nozawa D; Nakamura T; Chaki S
J Pharmacol Exp Ther; 2020 Nov; 375(2):276-285. PubMed ID: 32862143
[TBL] [Abstract][Full Text] [Related]
19. Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists.
Liedtke S; Flau K; Kathmann M; Schlicker E; Stark H; Meier G; Schunack W
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):43-50. PubMed ID: 12616340
[TBL] [Abstract][Full Text] [Related]
20. Effects of N-alpha-methyl-histamine on human H(2) receptors expressed in CHO cells.
Saitoh T; Fukushima Y; Otsuka H; Ishikawa M; Tamai M; Takahashi H; Mori H; Asano T; Anai M; Ishikawa T; Katsube T; Ogawa K; Kajiwara T; Omata M; Ohkawa S
Gut; 2002 Jun; 50(6):786-9. PubMed ID: 12010879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
